Cargando…
Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate Cancer
SIMPLE SUMMARY: Despite the improvement in the treatment options for prostate cancer patients, we still lack effective treatments when the cancer has spread outside the prostate. Therefore, there is an urgent need to develop new therapies that will work better in this setting. Our study has identifi...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760758/ https://www.ncbi.nlm.nih.gov/pubmed/33260953 http://dx.doi.org/10.3390/cancers12123540 |